SCHEMBL29651308

SCHEMBL29651308

COc1cc2c(cc1Nc1ncc(Cl)c(Cl)n1)CN(C)CC2

nearest known ligand 0.65

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ MAP4K1 Q92918 18/20 0.65
▸ ALK Q9UM73 2/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25947626 0.89 MAP4K1 (0.63) MAP4K1ALK
SCHEMBL30099018 0.86 MAP4K1 (0.62) MAP4K1ALK
SCHEMBL29520152 0.86 MAP4K1 (0.64) MAP4K1ALK
SCHEMBL29037890 0.86 MAP4K1 (0.64) MAP4K1ALK
SCHEMBL29801225 0.85 MAP4K1 (0.58) MAP4K1ALK
SCHEMBL28743739 0.85 MAP4K1 (0.58) MAP4K1ALK
SCHEMBL29800953 0.85 MAP4K1 (0.59) MAP4K1ALK
SCHEMBL30099063 0.84 MAP4K1 (0.62) MAP4K1
SCHEMBL24394224 0.84 MAP4K1 (0.62) MAP4K1ALK
SCHEMBL22864782 0.83 MAP4K1 (0.63) MAP4K1ALK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114555585-B HPK1 inhibitors and uses thereof 锐格药业公司 2025-02-11 — — CN disclosed
CN-114555585-A HPK1 inhibitors and uses thereof 上海齐鲁锐格医药研发有限公司 2022-05-27 — — CN disclosed
EP-3994133-A1 HPK1 INHIBITORS AND USES THEREOF Qilu Regor Therapeutics Inc. (CN) 2022-05-11 — — EP disclosed
Send feedback